The Biotech Growth Trust
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The Biotech Growth Trust's past years’ income statements indicate that its last revenue has increased compared to the previous period by 138% to $80,346,000. The net income raised on $74,600,000 and profit margin reached 93%. Total operating expenses were $3,851,000.

Profit Margin

The Biotech Growth Trust PLC (LSE:BIOG.L): Profit margin
2010 30.48M 28.68M 94.1%
2011 3.16M 2M 63.25%
2012 44.18M 40.51M 91.71%
2015 215.12M 214.26M 99.6%
2016 -126.69M -128.94M 101.78%
2018 -27.51M -29.78M 108.24%
2019 23.04M 21.1M 91.56%
2021 204.35M 200.42M 98.08%
2022 -209.71M -202.41M 96.52%
2024 80.34M 74.6M 92.85%

BIOG.L Income Statement (2010 – 2023)

2023 2021 2020 2018 2017 2015 2014 2012 2011 2010
Revenue
Revenue
80.34M-209.71M204.35M23.04M-27.51M-126.69M215.12M44.18M3.16M30.48M
Cost of revenue
3.11M0-17.76M-5.99M4.34M00000
Gross profit
77.23M-209.71M222.11M29.04M-31.86M-126.69M215.12M000
Operating exp.
Research and development
0000000000
Selling and marketing
71K70K63K57K000000
Total operating expenses
3.85M-7.44M3.79M1.75M2.03M2.00M735K3.63M1.16M1.79M
Operating income
76.49M-199.75M197.34M24.48M-29.05M-128.35M214.54M000
Other income (expenses), net
-1.73M-2.51M3.21M-3.2M2.38M-2.14M-5.01M000
Income before tax
74.75M-202.27M200.55M21.28M-29.54M-128.69M214.39M40.54M2.00M28.68M
Income tax expense
159K149K131K186K238K254K132K27K1K0
Net income
74.6M-202.41M200.42M21.1M-29.78M-128.94M214.26M40.51M2M28.68M
Earnings per share
Basic EPS
2.07-4.885.010.39-0.53-2.083.280.630.030.51
Diluted EPS
2.07-4.885.010.39-0.53-2.083.280.630.030.51
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source